In case you missed it: July 18 to July 22


A look back at the week's news.

Phase 3 ibrexafungerp data shows promising results for acute VVC treatment

The CANDLE open-label sub-study enrolled 24 patients with RVVC who failed to respond to fluconazole treatment, which was given as an initial 3-dose treatment over 7 days.

Study finds attitudes around older motherhood focus on negative outcomes

Investigators argue that much of the language around women who give birth later in life is rooted in ableism and ageism and is out of step with current childbirth trends.

Maternal exposure to PCOS increases risk of childhood hospitalizations

New research suggests being born to a mother with polycystic ovary syndrome was associated with a 32% increase in risk of childhood hospitalizations among offspring.

Hormone replacement therapy does not increase breast cancer recurrence, mortality in survivors

An analysis of data from more than 8400 postmenopausal women with a history of early-stage nonmetastatic, ER-positive breast cancer suggests there was no increase in risk of breast cancer recurrence or mortality observed with use of vaginal estrogen therapy or menopausal hormone therapy.

COVID-19 pregnancy data in the United States: July 18 update

Data on COVID-19 during pregnancy, as reported by the CDC, in collaboration with state, local, and territorial health departments and external partners.

Pregnancy outcomes affected by aerobic vaginitis

Aerobic vaginitis (AV) in pregnant Vietnamese women correlated with a higher risk of puerperal sepsis and negative pregnancy outcomes.

Related Videos
Discussing PCOS: misconceptions, management, encouragement | Image Credit:
The importance of diversity in obstetrics | Image Credit: ©
Study confirms efficacy of JADA against postpartum bleeding | Image Credit: © Amy Taneja MD - © Amy Taneja MD -
Matthew Zerden, MD
John Stanley, MD
Marci Bowers, MD | Image Credit:
Sean Esplin, MD
Jermaine Gray
Related Content
© 2023 MJH Life Sciences

All rights reserved.